Buchumschlag

European S2k guideline on chronic pruritus: in cooperation with the European Dermatology Forum (EDF)

Pruritus is a frequent symptom in medicine. Population-based studies show that one in five persons in the general population has suffered from chronic pruritus (CP) at least once in their lifetime, with a 12-month incidence of 7%. CP, which can affect all age groups, is associated with numerous, oft...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Weisshaar, Elke (VerfasserIn) , Müller, Simon (VerfasserIn) , Szepietowski, Jacek C. (VerfasserIn) , Dalgard, Florence (VerfasserIn) , Garcovich, Simone (VerfasserIn) , Kupfer, Jörg (VerfasserIn) , Gimenez-Arnau, Ana (VerfasserIn) , Lambert, Julien (VerfasserIn) , Mettang, Thomas (VerfasserIn) , Misery, Laurent (VerfasserIn) , Savk, Ekin (VerfasserIn) , Tschachler, Erwin (VerfasserIn) , Wallengren, Joanna (VerfasserIn) , Ständer, Sonja (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2025-08-22
In: Acta dermato-venereologica
Year: 2025, Jahrgang: 105, Pages: 1-68
ISSN:1651-2057
DOI:10.2340/actadv.v105.44220
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.2340/actadv.v105.44220
Verlag, kostenfrei, Volltext: https://medicaljournalssweden.se/actadv/article/view/44220
Volltext
Verfasserangaben:Elke Weisshaar, Simon Müller, Jacek C. Szepietowski, Florence Dalgard, Simone Garcovich, Jörg Kupfer, Ana Gimenez-Arnau, Julien Lambert, Thomas Mettang, Laurent Misery, Ekin Savk, Erwin Tschachler, Joanna Wallengren, Sonja Ständer
Beschreibung
Zusammenfassung:Pruritus is a frequent symptom in medicine. Population-based studies show that one in five persons in the general population has suffered from chronic pruritus (CP) at least once in their lifetime, with a 12-month incidence of 7%. CP, which can affect all age groups, is associated with numerous, often interdisciplinary medical conditions. It needs a precise diagnostic work-up to identify causes and relevant comorbidities. Management of CP comprises treatment of the underlying disease as well as topical and systemic therapies. Treating CP needs to be targeted, multimodal and performed in a step-wise procedure requiring an interdisciplinary approach. In recent years, novel on-label therapies have been approved for CP, including therapies for chronic prurigo and cholestatic pruritus. We present the updated European guideline on chronic pruritus by a team of European pruritus experts from different disciplines.
Beschreibung:Gesehen am 03.02.2026
Beschreibung:Online Resource
ISSN:1651-2057
DOI:10.2340/actadv.v105.44220

Ähnliche Einträge